Abstract:[Objective]Giant cell tumor of bone is notorious for its local aggressive behavior and its tendency to recur after operative treatment.Bisphosphonates is the drug of anti-osteoporosis.It is found also have anti-cancer effect recently.We conducted experiment examing the effect of bisphosphonates alendronate on the growth and survival of the cells.To study if bisphosphonates are capable of inducing cells death and significantly inhibiting their growth in vitro.[Method]Cells viability was detected by MTT Assay after the tumor cells were cured with different concentration and different time.Tumor cells apoptosis with in situ TUNEL assay and flow cytometry was detected.The active Caspase-3 was also detected.[Result]After exposure to alendronate,the cells exhibited the characteristic features of cell shrinkage,rounding and partial detachment,and demonstrated the lobulated appearance of apoptotic cells.It was much more prominent while the treating time prolonged or the concentration increased.Alendronate((5 200) M) treatment for 24 h,resulted in 2.79%~31.17% decrease in cell viability,and 11.13%~49.94% for 72 h,respectively.A significant dose-dependent and time-dependent decrease in the number of viable cells was observed in the GCT cells.After Alendronate treat for 24 h,the mean cell population in apoptosis was 14.32% at concentration 5 mmol/l,and 40.24% at 200 mmol/l.It was up to 18.41% and 42.22% respectively after 48 h.In Alendronate-treated GCT cells,Caspase-3 activation was observed.The cell response varied with doses of Alendronate showing the levels of Caspase-3 expression with a dose dependent response.[Conclusion]In conclusion,we demonstrated that bisphosphonate alendronate could inhibit GCT cells in the present study.This response was time-dependent and dose-dependent.Alendronate inducing apoptosis in GCT cells is mediated by the activation of Caspase-3.

Effects of Alendronate on the Proliferation and Osteogenic Differentiation of MG-63 Cells

Effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

The effects of Alendronate on bone mineral density in RA patients with osteoporosis or osteopenia

Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation

Effects of Alendronate Sodium on Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Effect of hydroxyapatite nanocrystals on proliferation and differentiation of preosteoblasts

Alendronate affects osteoprotegerin/receptor of nuclear factor κB-ligand activator expression in human bone marrow stroma cells in vitro

Influence of Alendronate on Proliferation of Rat Steoblasts

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors

Preliminary Study on Alendronate Inhibiting Two Oral Squamous Carcinoma Cell Lines

Effect of the Nanostructure of Porous Alumina on Growth Behavior of MG63 Osteoblast-Like Cells.

Study of the Alendronate inhibiting growth and inducing apoptosis of giant cell tumor of bone in vitro

Alendronate Stimulates Osteoblast Differentiation Through Pka-Stat3 And Stat1 In An Osteoporosis Rat Model

Effects of Local and Systemic Alendronate Delivery on Wear Debris-Induced Osteolysis in Vivo

Effects of Alendronate on Adipogenic Differentiation of Bone Marrow Stromal Cells Derived from Ovariectomized Rats

[Effects of IGF-I and BMP-2 Combined Application on Promoting Proliferation, Differentiation and Calcification of MC 3T3-E1 and NIH 3T3 Cells].

Alendronate Stimulates Osteoprotegerin Expression in Fibroblasts from Periprosthetic Membrane.

Effect of alendronate on bone turnover biomarkers in postmenopausal osteoporosis

Effects of Alendronate on the Periprosthetic Bone Ingrowth